Accuray (ARAY) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.30% |
| Dec 31, 2025 | -27.81% |
| Sep 30, 2025 | -32.40% |
| Jun 30, 2025 | 23.84% |
| Mar 31, 2025 | -33.36% |
| Dec 31, 2024 | 5.37% |
| Sep 30, 2024 | 12.87% |
| Jun 30, 2024 | 8.28% |
| Mar 31, 2024 | -29.08% |
| Dec 31, 2023 | -35.49% |
| Sep 30, 2023 | 19.84% |
| Jun 30, 2023 | 13.45% |
| Mar 31, 2023 | 21.12% |
| Dec 31, 2022 | 36.04% |
| Sep 30, 2022 | -1.24% |
| Jun 30, 2022 | 10.30% |
| Mar 31, 2022 | 25.45% |
| Dec 31, 2021 | 23.09% |
| Sep 30, 2021 | 18.82% |
| Jun 30, 2021 | 18.91% |
| Mar 31, 2021 | -4.05% |
| Dec 31, 2020 | 132.62% |
| Sep 30, 2020 | 22.48% |
| Jun 30, 2020 | -27.50% |
| Mar 31, 2020 | 46.72% |
| Dec 31, 2019 | 24.65% |
| Sep 30, 2019 | 22.46% |
| Jun 30, 2019 | 21.96% |
| Mar 31, 2019 | 51.82% |
| Dec 31, 2018 | -3.93% |
| Sep 30, 2018 | 17.53% |
| Jun 30, 2018 | -38.48% |
| Mar 31, 2018 | 31.34% |
| Dec 31, 2017 | 46.06% |
| Sep 30, 2017 | 36.97% |
| Jun 30, 2017 | -30.25% |
| Mar 31, 2017 | 36.92% |
| Dec 31, 2016 | 2.42% |
| Sep 30, 2016 | 23.31% |
| Jun 30, 2016 | 24.26% |
| Mar 31, 2016 | 65.31% |
| Dec 31, 2015 | -15.25% |
| Sep 30, 2015 | -3.36% |